Molecular diagnostic testing for infectious diseases using TMA technology

References

• Kohne DE, Steigerwalt AG, Brenner J. Nucleic acid probe specific for members of the genus Legionella. In: Legionella: Proceedings of the 2nd International Symposium. Thornsberry et al. (Ed.), American Society for Microbiology, Washington DC, USA, 107–108 (1984).
   Google Scholar
• Nelson NC, Kacian DL. Chemiluminescent DNA probes: a comparison of the acridinium ester and dioxetane detection systems and their use in clinical diagnostic assays. Clin. Chim. Acta 194, 73–90 (1990).
   PubMed Web of Science ®Google Scholar
• • This is the first description of the hybridization protection assay method for the homogeneous detection of DNA probes using acridinium ester molecules.
   Google Scholar
• Nelson NC, Reynolds MA, Arnold LJ, Jr. Detection of acridimium esters by chemiluminescence. In: Nonisotopic Probing, Blotting and Sequencing. Krick LJ (Ed.), Academic Press, San Diego, USA, 391–428 (1995).
   Google Scholar
• Evans KD, Nakasone AS, Sutherland PA et al. Identification of Mycobacterium tuberculosis and Mycobacterium avium-M. intracellulare directly from primary BACTEC cultures by using acridinium ester-labeled DNA probes. J. Clin. Microbiol. 30, 2427–2431 (1992).
   Google Scholar
• Chapin-Robertson K, Dahlberg S, Waycott S et al. Detection and identification of Mycobacterium directly from BACTEC bottles by using a DNA-rRNA probe. Diagn. Microbiol. Infect. Dis. 17, 203–207 (1993).
   Web of Science ®Google Scholar
• Reisner BS, Gatson AM, Woods GL. Use of Gen-Probe AccuProbes to identify Mycobacterium avium complex, Mycobacterium tuberculosis complex, Mycobacterium kansasii and Mycobacterium gordonae directly from BACTEC TB broth cultures. J. Clin. Microbiol. 32, 2995–2998 (1994).
   Google Scholar
• Limberger RJ, Biega A, Evanco A et al. Evaluation of culture and the Gen-Probe PACE 2 assay for detection of Neisseria gonorrhoeae and Chlamydia trachomatis in endocervical specimens transported to a state health laboratory. J. Clin. Microbiol. 30, 1162–1166 (1992).
   Google Scholar
• Yang LI, Panke ES, Leist PA et al. Detection of Chlamydia trachomatis endocervical infection in asymptomatic and symptomatic women: Comparison of Gen- Probe PACE 2 DNA probe test and tissue culture. Am. J .Obstet. Gynecol. 165, 1444– 1453 (1991).
   Google Scholar
• Warren R, Dwyer B, Plackett M et al. Comparative evaluation of detection assays for Chlamydia trachomatis. J. Clin. Microbiol. 31, 1663–1666 (1993).
   Web of Science ®Google Scholar
• Hale YM, Melton ME, Lewis JS et al. Evaluation of the PACE 2 Neisseria gonorrhoeae assay by three public health laboratories. J. Clin. Microbiol. 31, 451– 453 (1992).
   Google Scholar
• Hill CS. DNA probe assays for the detection of sexually transmitted diseases. Am. Clin. Lab. 10, 8 (1995).
   Google Scholar
• Iwen PC, Walker RA, Warren KL et al. Evaluation of nucleic acid-based test (PACE 2C) for simultaneous detection of Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical specimens. J. Clin. Microbiol. 33, 2587–2591 (1995).
   Google Scholar
• Heiter BJ, Bourbeau PP. Comparison of the Gen-Probe Group A Streptococcus Direct Test with culture and a rapid streptococcal antigen detection assay for diagnosis of streptococcal pharyngitis. J. Clin. Microbiol. 31, 2070–2073 (1993).
   Web of Science ®Google Scholar
• Tang YW, Persing DH. Molecular detection and identification of microorganisms. In: Manual of Clinical Microbiology. Murray PR et al. (Ed.), 215–144 (1999).
   Google Scholar
• • This is a comprehensive overview chapter on molecular diagnostics for infectious disease with a description of all of the major nucleic acid amplification technologies.
   Google Scholar
• Mahoney J, Chang S, Jang D et al. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction and transcription-mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity. J. Clin. Microbiol. 36(11), 3122–3126 (1998).
   Google Scholar
• • This is a detailed study of inhibitory factors in nucleic acid amplification technology assays for CT.
   Google Scholar
• Gronowski AM, Copper S, Baorto D, Murray P. Reproducibility problems with the abbott laboratories LCX assay for Chlamydia trachomatis and Neisseria gonorrhoeae. J. Clin. Microbiol. 38(6), 2416–2418 (1999).
   Google Scholar
• Peterson EM, Darrow V, Blanding J, Aarnaes S, de la Maza LM. Reproducibility problems with the amplicor PCR Chlamydia trachomatis test. J. Clin. Microbiol. 35(4), 957–959 (1997).
   Google Scholar
• Farrell DJ. Evaluation of amplicor Neisseria gonorrhoeae PCR using cppB nested PCR and 16S rRNA PCR. J. Clin. Microbiol. 37(2), 386–390 (1999).
   Google Scholar
• Nelson NC, Cheikh AB, Matsuda E et al. Simultaneous detection of multiple nucleic acid targets in a homogeneous format. Biochemistry 35, 8429–8438 (1996).
   Web of Science ®Google Scholar
• • This paper describes the dual kinetic assay technology for the detection of multiple infectious organisms in detail.
   Google Scholar
• Heifets LB, Good RC. Current laboratory methods for the diagnosis of tuberculosis. In: Tuberculosis. Bloom BR (ed.), ASM Press, Washington, DC, USA, 85–110 (1994).
   Google Scholar
• Abe C, Hirano K, Wada M et al. Detection of Mycobacterium tuberculosis in clinical specimens by polymerase chain reaction and Gen-Probe amplified mycobacterium tuberculosis direct test. J. Clin. Microbiol. 31, 3270–3274 (1993).
   Google Scholar
• Jonas V, Alden MJ, Curry JL et al. Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by amplification of rRNA. J. Clin. Microbiol. 32, 2410–2416 (1993).
   Google Scholar
• • The first comprehensive reports on the first FDA-approved nucleic acid amplification technology for the detection of M. tuberculosis in clinical specimens.
   Google Scholar
• Catanzaro A, Perry S, Clarridge S et al. The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis. Results of a multicenter prospective trial. JAMA 283, 639–645 (2000).
   Web of Science ®Google Scholar
• • The most recent FDA clinical trial results for the MTD assay that led to the approval for use of the assay on both smear-positive and smear-negative specimens.
   Google Scholar
• Woods GL, Bergmann JS, Williams- Bouyer N. Clinical evaluation of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for rapid detection for Mycobacterium tuberculosis in select nonrespiratory specimens. J. Clin. Microbiol. 39, 747–749 (2001).
   Google Scholar
• Scarparo C, Piccoloi O, Rigon A, Ruggiero G, Scagnelli M, Piersimoni C. Comparison of enhanced mycobacterium tuberculosis amplified direct test with COBAS AMPLICOR Mycobacterium tuberculosis assay for direct detection of Mycobacterium tuberculosis complex in respiratory and extrapulmonary specimens. J. Clin. Microbiol. 38, 1559–1562 (2000).
   Google Scholar
• Bermann JS, Yuoh G, Fish G, Woods GL. Clinical evaluation of the enhanced Gen- Probe Amplified Mycobacterium Tuberculosis Direct Test for rapid diagnosis of tuberculosis in prison inmates. J. Clin. Microbiol. 37, 1419–1425 (1999).
   Google Scholar
• Gamboa F, Fernandez G, Padilla E et al. Comparative Evaluation of initial and new versions of the Gen-Probe amplified mycobacterium tuberculosis direct test for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J. Clin. Microbiol. 36, 684–689 (1998).
   Google Scholar
• Della-Latta P, Whittier S. Comprehensive evaluation of performance, laboratory application and clinical usefulness of two direct amplification technologies for the detection of Mycobacterium tuberculosis complex. Am. J. Clin. Pathol. 110, 301–310 (1998).
   Google Scholar
• Wang SX, Tay L. Evaluation of three nucleic acid amplification methods for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J. Clin. Microbiol. 37, 1932–1934 (1999).
   Google Scholar
• Bergmann JS, Woods GL. Enhanced mycobacterium tuberculosis direct test for detection of M. tuberculosis complex in positive ESP II broth cultures of nonrespiratory specimens. Diag. Microbiol. Infect. Dis. 35, 245–248 (1999).
   Web of Science ®Google Scholar
• Behr MA, Warren SA, Salamon H et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 353, 444–449 (1999).
   Web of Science ®Google Scholar
• • A study on the infectivity of smearnegative TB patients.
   Google Scholar
• Schachter J. Chlamydial infections. In: Infectious Diseases. Gorbach SL, Bartlett JG, Blacklow NR (Eds.), W.B. Saunders Co., Philadelphia, USA, 817–822 (1992).
   Google Scholar
• Peeling RW, Brunham RC. Molecular techniques for the laboratory identification of Chlamydia trachomatis. JIFCC 6, 78–82 (1994).
   Google Scholar
• Warren R, Dwyer B, Plackett M et al. Comparative evaluation of detection assays for Chlamydia trachomatis. J. Clin. Microbiol. 31, 1663–1666 (1993).
   Web of Science ®Google Scholar
• Thomas BJ, MacLeod PE, Hay PE et al. Limited value of two widely used enzyme immunoassays for detection of Chlamydia trachomatis in women. Eur. J. Clin. Microbiol. Infect. Dis. 13, 651–655 (1994).
   Web of Science ®Google Scholar
• Washington AE, Browner WS, Korenbrot CC et al. Cost-effectiveness of combined treatment for endocervical gonorrhea considering co-infection with Chlamydia trachomatis. JAMA 257, 2056–2060 (1987).
   Web of Science ®Google Scholar
• Schachter J. Nucleic acid amplification technologies to diagnose Chlamydia trachomatis genital infection: a promise still unfulfilled. Expert Rev. Mol. Diagn. 1(2) 137– 144 (2001).
   Google Scholar
• •• A comprehensive review paper on nucleic acid amplification technology assays for Chlamydia trachomatis for those readers who need more detail on the subject.
   Google Scholar
• Martin D, Hook E III, Ferrero D et al. Comparison of three nucleic acid amplification tests and N. gonorrhoeae culture for the detection of C. Trachomatis and N. gonorrhoeae using a rotating standard. In: Sexually Transmitted Infections. Kohl P, Jodl S (Eds.), Monduzzi Editore SPA, 75–79 (2001).
   Google Scholar
• •• This and the following four references report on the clinical trial for the APTIMA Combo 2 assay.
   Google Scholar
• Moncada J, Schacter J, Hook EW III et al. The effect of urine testing in evaluations of the sensitivity of Gen- Probe APTIMA Combo 2 Assay on cervical swabs for Chlamydia trachomatis. the infected patient standard reduces sensitivity of single site evaluation. In: Sexually Transmitted Infections. Kohl P, Jodl, S (Eds.), Monduzzi Editore SPA, 43–47 (2001).
   Google Scholar
• Ferrero DV, Gaydos CA, Quinn TC et al. Multicenter clinical trial performance of the new Gen-Probe APTIMA Combo 2 assay for detecting Chlamydia trachomatis and Neisseria gonorrhoeae in female and male urine specimens. In: Sexually Transmitted Infections. Kohl P, Jodl S (Eds.), Monduzzi Editore SPA, 49–53 (2001).
   Google Scholar
• Turner B, Weissfeld A, Vance P et al. Comparison of the Gen-Probe APTIMA Combo 2 Assay with chlamydial culture and the PCR and LCR diagnostic tests. In: Sexually Transmitted Infections. Kohl P, Jodl S (Eds.), Monduzzi Editore SPA, 61–65 (2001).
   Google Scholar
• Bott M, Bixby T, Castillo M et al. APTIMA Combo 2 analytical performance with C. trachomatis and N. gonorrhoeae. In: Sexually Transmitted Infections. Kohl P, Jodl S (Eds.), Monduzzi Editore SPA, 55–60 (2001).
   Google Scholar
• Chernesky MA, Chong S, Jang DE, Song X, Mahoney JB. Lack of female urinary inhibitors to Chlamydia trachomatis nucleic acid amplification in the Gen-Probe APTIMA Combo 2 assay. Presented at the Infectious Disease Society of America, San Francisco, USA (2001).
   Google Scholar
• • A study demonstrating the effectiveness of target capture technology for eliminating inhibition in nucleic acid amplification technology tests.
   Google Scholar
• Mimms L. Transcription-mediated amplification assays for blood-screening: HIV-1/HCV assay, HIV-1/HCV/HBV triplex, HIV-1/HCV/HBV discriminatory assays. Presented at the Transfusion 2001 Conference, Cambridge, UK (2000).
   Google Scholar
• Kolk DP, Friedenberg MC. Detection of HIV-1 and HCV amplification products. IVD Technology 7(3), 55–62 (2001).
   Google Scholar
• • A review paper detailing the HIV-1, HCV nucleic acid amplification technology assays for blood bank use.
   Google Scholar
• Stramer SL, Caglioti S, Strong DM. Nucleic acid amplification technology of the United States and Canadian Blood Supply. Transfusion 40, 1165–1168 (2000).
   Google Scholar
• Hill C. Automating nucleic acid amplification tests. IVD Technology 6(7), 36–45 (2000).
   Google Scholar
• • An overview of the development of automated nucleic acid amplification technology tests.
   Google Scholar